Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
present at the seventh annual JMP Securities Healthcare Conference being
held at the Peninsula Hotel in New York City. Timothy P. Clackson,
Ph.D., president of research and development and chief scientific
officer, will provide an overview of the Company’s business on Friday,
July 13, 2012 at 10:30 a.m. (ET).
The ARIAD presentation at the JMP Securities 2012 Healthcare Conference
will be webcast live and can be accessed by visiting the investor
relations section of the Company's website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD’s approach to
structure-based drug design has led to several internally discovered,
molecularly targeted product candidates for drug-resistant or
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia and non-small cell lung cancer. For additional information,
or follow ARIAD on Twitter